Name: Latest research reports of Alkem Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Alkem Laboratories Ltd.
Rating: 1
Author: BOB Capital Markets Ltd.

Alkem Laboratories Ltd.

NSE: ALKEM | BSE: 539523 | ISIN: INE540L01014 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

5668.5000 25.00 (0.44%)

NSE Nov 07, 2025 15:31 PM

Near 52W High of ₹5958.90

Volume: 226.7K

Alkem Laboratories Ltd.

20 May 2023

5668.50

0.44%

Alkem Labs (SELL): Margin improvement key for revival

Sell: Alkem Laboratories Ltd.

BOB Capital Markets Ltd.

Q4 EBITDA/PAT of Rs 3.5bn/Rs 710mn well short of consensus by 21%/ 79% primarily due to higher operating costs

Alkem Laboratories Ltd. is trading above all available SMAs